Prospective Randomized Blinded Placebo-Controlled Phase 2b Trial Of An Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells(DC) Vaccine Vs Unloaded YCWP + DC In Stage 3 And Stage IV (Resected) Melanoma To Prevent Recurrence
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Malignant Melanoma Of Skin
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
-
Other Inclusion Criteria:
1. Patient must have stage III or IV completely resectable melanoma
2. Patient must be clinically disease-free after surgery
You may not be eligible for this study if the following are true:
-
1. Evidence of residual disease after surgery
2. Immune deficiency disease or known history of HIV, HBV, HCV
3. Receiving immunosuppressive therapy including chronic steroids, methotrexate, or other known immunosuppressive agents
4. Pregnancy or breastfeeding
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.